Dr. Brian Zambrowicz, Ph.D Has Joined Nuevolution as Director and Senior Scientific Advisor to the Board of Directors
Brian Zambrowicz, Ph.D. is one of the co-founders of Lexicon Pharmaceuticals Inc. and has served the company as Executiv…
Brian Zambrowicz, Ph.D. is one of the co-founders of Lexicon Pharmaceuticals Inc. and has served the company as Executiv…
Nuevolution A/S today announced that it has entered an exclusive license agreement with a subsidiary of Merck & Co., Inc…
The Institute of Cancer Research (ICR), London, Cancer Research Technology (CRT), London and Nuevolution A/S, Copenhagen…
Nuevolution A/S today announced that it has entered into a non-exclusive technology licensing agreement with Novartis fo…
Nuevolution A/S, a leading small molecule lead discovery company, today announced that Ton Berkien will join the company…
Cancer Research Technology (CRT), the commercial arm of Cancer Research UK, and Denmark-based drug discovery company Nue…
Nuevolution A/S announces a corporate update. Professor Dr. Jutta Heim has joined Nuevolution as Director and Senior…
Nuevolution A/S today announced that it has entered into a scientific collaboration with Duke University, the Howard Hug…
Nuevolution teams with key scientific advisors to assist the progression of its internal drug discovery programs within…
Nuevolution A/S today announced that it has received a milestone payment derived from its collaboration with Boehringer…